id: NEW:sarcopenia_prevalence_cirrhosis_to_all_cause_mortality_rate
name: Sarcopenia Prevalence in Cirrhosis Patients â†’ All-Cause Mortality Rate
from_node:
  node_id: NEW:sarcopenia_prevalence_cirrhosis
  node_name: Sarcopenia Prevalence in Cirrhosis Patients
to_node:
  node_id: all_cause_mortality_rate
  node_name: All-Cause Mortality Rate
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Cirrhosis leads to metabolic dysfunction including impaired protein synthesis,
  hyperammonemia, and systemic inflammation, which contribute to skeletal muscle wasting
  (sarcopenia)'
- 'Step 2: Sarcopenia reflects severe catabolic state and depleted physiological reserves,
  compromising the body''s ability to respond to metabolic stressors, infections,
  and disease complications'
- 'Step 3: Reduced muscle mass impairs immune function, respiratory capacity, and
  physical performance, increasing vulnerability to complications such as infections,
  hepatic encephalopathy, and respiratory failure'
- 'Step 4: Sarcopenic patients have diminished capacity to tolerate treatments including
  liver transplantation and interventions for portal hypertension, leading to worse
  outcomes'
- 'Step 5: The combination of reduced functional reserve and increased complication
  risk results in approximately 2-fold higher mortality risk in cirrhotic patients
  with sarcopenia'
evidence:
  quality_rating: A
  n_studies: 22
  primary_citation: 'Xinxing Tantai et al. 2022. Effect of sarcopenia on survival
    in patients with cirrhosis: A meta-analysis. Journal of hepatology.'
  supporting_citations: []
description: Sarcopenia, affecting approximately 37.5% of patients with cirrhosis,
  is independently associated with a 2.3-fold increased risk of mortality. This association
  persists across patient subgroups stratified by sex, underlying liver disease etiology,
  and severity of hepatic dysfunction. The relationship is supported by quantitative
  muscle mass index analysis showing continuous association between muscle mass and
  survival. Higher prevalence observed in males, alcohol-related liver disease, and
  advanced cirrhosis (Child-Pugh C).
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 2.3
    type: hazard_ratio
    ci_lower: 2.01
    ci_upper: 2.63
  p_value: null
  sample_size: 6965
moderators:
- name: Sex
  direction: strengthens
  strength: moderate
  description: Sarcopenia prevalence higher in males, but association with mortality
    similar across sexes
- name: Liver disease etiology
  direction: strengthens
  strength: moderate
  description: Higher sarcopenia prevalence in alcohol-associated liver disease; association
    with mortality consistent across etiologies
- name: Severity of hepatic dysfunction (Child-Pugh class)
  direction: strengthens
  strength: strong
  description: Sarcopenia prevalence higher in Child-Pugh class C (up to 50%); association
    with mortality consistent across severity levels
- name: Duration and severity of sarcopenia
  direction: strengthens
  strength: strong
  description: Mortality rate increased with greater severity or longer durations
    of sarcopenia
